Alnylam Pharmaceuticals (United States)

579 papers and 42.3k indexed citations i.

About

In recent decades, authors affiliated with Alnylam Pharmaceuticals (United States) have published 579 papers, which have received a total of 42.3k indexed citations. Scholars at this organization have produced 395 papers in Molecular Biology, 54 papers in Cancer Research and 50 papers in Immunology on the topics of RNA Interference and Gene Delivery (161 papers), Advanced biosensing and bioanalysis techniques (118 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (90 papers). Their work is cited by papers focused on Molecular Biology (30.0k citations), Cancer Research (8.9k citations) and Immunology (5.8k citations). Authors at Alnylam Pharmaceuticals (United States) collaborate with scholars in United States, United Kingdom and Germany and have published in prestigious journals including Nature, Cell and New England Journal of Medicine. Some of Alnylam Pharmaceuticals (United States)'s most productive authors include Muthiah Manoharan, Kevin Fitzgerald, Martin A. Maier, Kallanthottathil G. Rajeev and Klaus Charissé.

In The Last Decade

Fields of papers published by authors at Alnylam Pharmaceuticals (United States)

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers affiliated with Alnylam Pharmaceuticals (United States) at the time of their publication. Nodes represent fields, and links connect fields that are likely to share authors.

Countries citing scholars working at Alnylam Pharmaceuticals (United States)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Alnylam Pharmaceuticals (United States). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Alnylam Pharmaceuticals (United States) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alnylam Pharmaceuticals (United States) more than expected).

Rankless by CCL
2025